🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 427746102 (prev. 00202J104 )
- Market Cap
- Large Cap
- Previous Symbol
- APPAD (changed 1/13/2014)
- Previous Name
- A.P. Pharma, Inc.
Business: Heron Therapeutics, Inc., formerly A.P. Pharma, Inc. is a specialty pharmaceutical company developing products using its proprietary Biochronomer polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks. The Company's lead product, Sustol (formerly known as APF-530), is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting.
Notes: The Company changed its name to Heron Therapeutics, Inc. and, in support of the Company’s relisting on the NASDAQ, effected a 1-for-20 reverse stock split, both effective January 13, 2014.
Company Contact
- CEO
- Craig Collard
- CFO
- Ira Duarte
- Headquarters
- 100 Regency Forest Drive, Suite 300, Cary, NC 27518
- Phone
- 858-251-4400
- Fax
- 650-365-6490
- Investor Relations
- David Szekeres · 858-251-4447 · ir@herontx.com